Canadian Immunization Guide
Seventh Edition - 2006

Table of Contents

Message from the Chief Public Health Officer, Public Health Agency of Canada

Preface

Preamble

National Advisory Committee on Immunization - Membership List

Part 1
General Guidelines

General Considerations
Table 1. Type and Contents of Vaccines Currently Approved for Use in Canada (May 2006)
The Benefits of Vaccines
National Guidelines for Immunization Practices
Communicating Effectively about Immunization
Principles of Combination Vaccines
Principles of Vaccine Interchangeability
Vaccine Administration Practices
Storage and Handling of Immunizing Agents
Timing of Vaccine Administration
Recent Administration of Human Immune Globulin Products
Immunization Records

Part 2
Vaccine Safety and Adverse Events Following Immunization

Vaccine Safety
General Contraindications and Precautions
Anaphylaxis: Initial Management in Non-Hospital Settings
Anaphylactic Hypersensitivity to Egg and Egg-Related Antigens

Part 3
Recommended Immunization

Recommended Immunization Schedules
Immunization of Adults
Immunization of Children and Adults with Inadequate Immunization Records
Immunization in Pregnancy and Breast-Feeding
Immunization of Infants Born Prematurely
Immunization of Patients in Health Care Institutions
Immunization of Immunocompromised Persons
Immunization of Persons with Neurologic Disorders
Immunization of Persons with Bleeding Disorders
Immunization of Travellers
Immunization of Persons New to Canada

Part 4
Active Immunizing Agents

Bacille Calmette-Guérin (BCG) Vaccine
Cholera Vaccine
Diphtheria Toxoid
Haemophilus Vaccine
Hepatitis A Vaccine
Hepatitis B Vaccine
Hepatitis Vaccines Combined
Influenza Vaccine
Japanese Encephalitis Vaccine
Measles Vaccine
Meningococcal Vaccine
Mumps Vaccine
Pertussis Vaccine
Pneumococcal Vaccine
Poliomyelitis Vaccine
Rabies Vaccine
Rubella Vaccine
Smallpox Vaccine
Tetanus Toxoid
Typhoid Vaccine
Varicella Vaccine
Yellow Fever Vaccine

Part 5
Passive Immunization

Passive Immunizing Agents
Immune Globulin (Human)
Recommended Usage
     Measles
     Hepatitis A
     Rubella
     Hepatitis C
Safety of Immunoglobulin Preparations
Adverse Reactions
Contraindications and Precautions
Specific Immune Globulins
     Botulism antitoxin (equine)
     Diphtheria antitoxin (equine)
     Hepatitis B immune globulin (HBIg)
     Rabies immune globulin (RabIg)
     Palivizumab (RSVAb)
     Tetanus immune globulin (TIg)
     Varicella-zoster immune globulin (VarIg)

Appendix
Abbreviations for Products Available in Canada

Index

Comparison of Effects of Diseases and Vaccines

---

For additional copies, contact:

Publishing and Depository Services Public Works and Government Services Canada, Ottawa, Ontario K1A 0S5

Telephone: 613-941-5995 or 1-800-635-7943
Fax: 613-954-5779 or 1-800-565-7757
E-mail: publications@pwgsc.gc.ca
Web: http://publications.gc.ca

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Minister of Public Works and Government Services, Ottawa, Ontario K1A 0S5

© Her Majesty the Queen in Right of Canada, represented by the Minister of Public Works and Government Services Canada, 2006